Catherine Glenn Foster, an Associate Scholar at the Charlotte Lozier Institute, was an invited witness at the most recent hearing for the Select Investigative Panel on Infant Lives. The Panel is a subcommittee of the House Energy and Commerce Committee and is charged with investigating the trafficking of body parts from babies killed in abortion. After more than fifteen years of federal silence on the issue, the Investigative Panel hopes to clarify points of federal law – especially those pertaining to what constitutes illegal profiting from the sale of baby body parts.
During Wednesday’s hearing on the price of fetal tissues, Representative Mia Love (R—UT) asked Ms. Foster: “Who protects the woman’s interests in each case? Who protects the minor’s interests in each case?” Foster, who revealed during the hearing that she herself is post-abortive, told Rep. Love that nobody advocates for women and minor girls undergoing abortions. Despite having no advocate, however, women and girls are asked by abortion mill staff to make a profound decision about whether or not to “donate” their baby’s body to the abortion mill after the abortion.
Pro-Life concern for those women continuously fell on the deaf ears of the Democrat Minority on the panel. In fact, less than thirty seconds after Ms. Foster decried the dearth of support and privacy protection with which abortive women are faced, Representative Jerrold Nadler (D—NY) denounced the entire investigative hearing as “farcical.” He slammed Republicans for what he called their “dual purpose” of “smearing organizations” (i.e., Planned Parenthood and StemExpress), and “eliminating women’s choices and degrading their doctors.” The one woman in the room who divulged her own history with abortion was written-off completely in favor of a mythological, ideological perspective on abortion’s effect on women.
According to committee chairwoman, Representative Marsha Blackburn (R—TN), the Select Investigative Panel on Infant Lives has been given until the end of the year to conclude the investigation. Progress has been stalled, however, by the refusal of StemExpress to respond appropriately to subpoenas for crucial documents needed to proceed with a full spectrum of evidence.
Watch the full hearing below.